Uninsured patients who undergo surgery to remove a brain tumor could be twice as likely to die in the hospital as those who have the same operation but are privately insured, new Johns Hopkins research suggests. In teaching ...
Nov 19, 2012
0
0
(HealthDay)—Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online ...
Oct 21, 2012
0
0
(Medical Xpress) -- A recent study from scientists at the Friedrich Miescher Institute for Biomedical Research has identified a novel target for the treatment of malignant brain tumors. The scientists found that the Mer receptor ...
Jun 18, 2012
0
0
Vincent DiNapoli, MD, Ph.D., a neurosurgeon with Mayfield Brain & Spine and Director of the Brain Tumor Center at The Jewish Hospital-Mercy Health, continued to evolve the standard of care this month when he became the first ...
Feb 26, 2020
0
38
(HealthDay)—Senator John McCain's long battle with brain cancer may be nearing an end, with his family announcing Friday that he will no longer receive treatment for the condition.
Aug 24, 2018
0
1
Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). ...
Jul 13, 2016
0
1
The research thoroughly reviews the importance of the blood-brain barrier (BBB) and the blood-tumor barrier (BTB) along with the current status and future perspectives of interesting physical and surgical strategies to circumvent ...
Mar 9, 2016
0
12
The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, ...
Jun 17, 2014
0
1
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
May 16, 2012
0
0
Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant ...
Feb 1, 2012
0
0
